<
 / Physicians

Discontinued drug: Attapulgite 40 mg/mL oral suspension

Date

Issue: After a recent drug recall affecting all stock on the market, attapulgite (Kaopectate®) 40 mg/mL oral suspension has now been discontinued in Canada. NH does not currently have any supply on hand in any facilities. Attapulgite is indicated for treatment of mild to moderate diarrhea.

Date: August 6, 2021

Further information and practice implications

Share this page